Am J Clin Nutr 1965, 16: 229-231
The surrounding muscle will absorb the medication right away
Additionally, BPC-157 modulates the adrenaline and noradrenaline systems by counteracting both beta-adrenergic overstimulation (e.g., isoprenaline) and blockade (e.g., sotalol), preventing resultant hemodynamic collapse, multiorgan failure, and vascular occlusion-like syndromes in rodent models [41, 48, 49]
Any compound that potentiates this pathway carries a theoretical risk of promoting neoplastic processes (PMID: 34179015) No Chronic Toxicity Data: Long-term effects of sustained HGF/c-Met potentiation are unstudied even in animal models Uncharacterized Dose-Response: The relationship between Dihexa dose and adverse effects in any living system is poorly defined beyond acute preclinical studies No Regulatory Review: Dihexa has never undergone the systematic safety evaluation required for regulatory submission Safety Comparison Summary: Cerebrolysin has a known, well-characterized safety profile from decades of clinical use

Expected timeline: Week 1 to 2: Initial reduction in inflammation and pain Week 2 to 4: Meaningful improvement in nerve-related symptoms (reduced radiating pain, improved sensation) Week 4 to 6: Continued structural healing, further functional improvement Post-protocol: Maximum benefits from a single course typically manifest by week 8 to 12 as tissue remodeling continues Use the SeekPeptides peptide calculator to determine exact dosing based on your vial concentration and desired dose